Search for content, post, videos

Cellaviva in new agreement

Diamyd’s associated company Cellaviva has signed an agreement regarding the European distribution rights for a stem cell product developed by StemBioSys, a privatetly held biomedical company based in Texas, USA.
The agreement entails that Cellaviva becomes the exclusive distributor for StemBioSys’ products in Sweden and Denmark with non-exclusive rights covering the rest of Europe. The agreement will initially cover StemBioSys’ cell expansion product BM-HPME. Future products may be added to the agreement as they become available.

Leave a Reply

Your email address will not be published. Required fields are marked *

10 − 10 =